Study of CDR132L for heart failure with preserved pumping function
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if CDR132L can improve heart structure and function in people with a type of heart failure where the heart pumps normally but is stiff and thickened. It may help if you have heart failure with preserved ejection fraction and a thickened heart muscle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 84 years old.
- You have had heart failure symptoms for at least 3 months and need a water pill (diuretic) weekly.
- Your heart's pumping strength is normal (50% or more) but you have a thickened heart muscle as seen on an ultrasound.
- You have a certain level of a heart strain marker (NT-proBNP) in your blood.
- Your kidney function is good enough (estimated filtration rate above 30).
- You have not had a heart attack, unstable chest pain, or heart failure hospital stay in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called CDR132L to see if it improves heart structure and function in people with heart failure who have a thickened heart muscle and reduced pumping ability. Participants will be randomly assigned to receive either the study drug or a placebo.
This study tests an experimental medicine called NNC0537-1482 for people with heart failure. It aims to see if the medicine helps improve symptoms and heart function.
This study is testing better ways to understand and manage heart failure where the heart pumps normally but still doesn't work as well as it should. It looks at people with symptoms like shortness of breath and fatigue, using blood tests and heart imaging to check eligibility.
This study looks at how the heart muscle works in people with a type of heart failure where the heart pumps normally but doesn't fill properly. It aims to understand the cause better, which could lead to new treatments.
This trial tests a treatment intended to improve how heart muscle cells handle calcium, which may help heart failure symptoms and heart function. It is mainly for people with advanced heart failure and a low pumping strength of the heart.
This study tests an experimental drug called LY3971297 to see if it can help people with chronic heart failure. It aims to find out if the drug is safe and if it improves heart function.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.